id int64 | testing_level string | lab_id string | country_income string | region_type string | has_HPLC int64 | has_dissolution_apparatus int64 | has_mass_spec int64 | WHO_prequalified_lab int64 | staff_analysts int64 | medicine_name string | therapeutic_category string | dosage_form string | storage_requirement string | reference_price_usd float64 | collection_point string | registered_product int64 | manufacturer_country string | WHO_prequalified_product int64 | year int64 | quarter int64 | primary_test_method string | quality_test_result string | sf_classification string | failure_type string | API_content_pct_label float64 | dissolution_pass int64 | turnaround_days int64 | confirmatory_test_done int64 | regulatory_action_taken int64 | product_recalled int64 | manufacturer_notified int64 | WHO_alert_issued int64 | estimated_patient_exposure int64 | report_to_WHO_GSM int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | regional_lab | QCL_0008 | low_income | rural | 1 | 0 | 0 | 0 | 5 | amoxicillin_500mg | antibiotic | capsule | ambient | 0.02 | private_pharmacy | 1 | unknown | 0 | 2,023 | 4 | thin_layer_chromatography | pass | compliant | not_applicable | 96.4 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2 | regional_lab | QCL_0068 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 6 | ciprofloxacin_500mg | antibiotic | tablet | ambient | 0.04 | public_hospital_pharmacy | 1 | local_SSA | 0 | 2,024 | 4 | HPLC | pass | compliant | not_applicable | 100.8 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3 | regional_lab | QCL_0055 | low_income | rural | 1 | 0 | 0 | 0 | 7 | cotrimoxazole_480mg | antibiotic | tablet | ambient | 0.01 | street_vendor | 1 | India | 1 | 2,024 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 98 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4 | regional_lab | QCL_0003 | low_income | rural | 1 | 0 | 0 | 0 | 7 | doxycycline_100mg | antibiotic | capsule | ambient | 0.03 | private_pharmacy | 1 | China | 0 | 2,024 | 1 | HPLC | fail | substandard | insufficient_API | 63 | 0 | 38 | 0 | 0 | 0 | 0 | 0 | 28 | 0 |
5 | regional_lab | QCL_0026 | low_income | urban | 1 | 0 | 0 | 0 | 4 | metronidazole_400mg | antibiotic | tablet | ambient | 0.02 | street_vendor | 0 | India | 0 | 2,022 | 1 | UV_spectrophotometry | fail | falsified | no_API_detected | 0 | 0 | 40 | 0 | 0 | 0 | 0 | 0 | 22 | 0 |
6 | regional_lab | QCL_0021 | low_income | urban | 1 | 0 | 0 | 0 | 4 | artemether_lumefantrine | antimalarial | tablet | ambient | 0.04 | private_clinic | 1 | unknown | 0 | 2,024 | 3 | thin_layer_chromatography | pass | compliant | not_applicable | 99.1 | 1 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
7 | regional_lab | QCL_0050 | low_income | urban | 1 | 0 | 0 | 0 | 3 | artesunate_injection | antimalarial | injection | ambient | 0.8 | informal_market | 1 | unknown | 0 | 2,023 | 1 | HPLC | pass | compliant | not_applicable | 98.3 | 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
8 | regional_lab | QCL_0037 | low_income | peri_urban | 1 | 0 | 0 | 0 | 6 | SP_sulfadoxine_pyrimethamine | antimalarial | tablet | ambient | 0.03 | private_pharmacy | 1 | USA | 0 | 2,021 | 4 | UV_spectrophotometry | fail | substandard | insufficient_API | 62.9 | 0 | 43 | 0 | 1 | 0 | 1 | 0 | 28 | 0 |
9 | regional_lab | QCL_0044 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 6 | chloroquine_250mg | antimalarial | tablet | ambient | 0.01 | public_hospital_pharmacy | 1 | unknown | 0 | 2,024 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 98.6 | 1 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10 | regional_lab | QCL_0002 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 4 | paracetamol_500mg | analgesic | tablet | ambient | 0.005 | public_hospital_pharmacy | 1 | India | 1 | 2,023 | 4 | GPHF_Minilab | pass | compliant | not_applicable | 96.3 | 1 | 37 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
11 | regional_lab | QCL_0040 | low_income | urban | 1 | 0 | 0 | 0 | 3 | ibuprofen_400mg | analgesic | tablet | ambient | 0.01 | private_clinic | 0 | China | 0 | 2,021 | 3 | thin_layer_chromatography | pass | compliant | not_applicable | 95 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
12 | regional_lab | QCL_0045 | low_income | peri_urban | 1 | 0 | 0 | 0 | 5 | metformin_500mg | antidiabetic | tablet | ambient | 0.01 | private_clinic | 0 | India | 0 | 2,021 | 4 | UV_spectrophotometry | pass | compliant | not_applicable | 104.6 | 1 | 53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
13 | regional_lab | QCL_0035 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 5 | amlodipine_5mg | antihypertensive | tablet | ambient | 0.01 | wholesale_distributor | 0 | China | 0 | 2,022 | 2 | UV_spectrophotometry | pass | compliant | not_applicable | 93.7 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
14 | regional_lab | QCL_0022 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 2 | omeprazole_20mg | GI | capsule | ambient | 0.03 | public_hospital_pharmacy | 1 | India | 1 | 2,024 | 1 | HPLC | pass | compliant | not_applicable | 98.6 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
15 | regional_lab | QCL_0057 | low_income | urban | 1 | 0 | 0 | 0 | 7 | ORS_sachet | essential | powder | ambient | 0.05 | public_health_centre | 0 | India | 0 | 2,023 | 1 | UV_spectrophotometry | fail | substandard | dissolution_failure | 83.1 | 0 | 17 | 1 | 0 | 0 | 0 | 0 | 5 | 0 |
16 | regional_lab | QCL_0064 | upper_middle_income | rural | 1 | 0 | 0 | 0 | 7 | oxytocin_10IU | maternal | injection | cold_chain | 0.15 | private_pharmacy | 0 | India | 0 | 2,021 | 4 | UV_spectrophotometry | pass | compliant | not_applicable | 104.2 | 1 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
17 | regional_lab | QCL_0059 | low_income | rural | 1 | 0 | 0 | 0 | 9 | insulin_regular | antidiabetic | injection | cold_chain | 5 | informal_market | 0 | local_SSA | 0 | 2,021 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 99.2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
18 | regional_lab | QCL_0050 | low_income | rural | 1 | 0 | 0 | 0 | 8 | TLD_dolutegravir | ARV | tablet | ambient | 0.12 | public_hospital_pharmacy | 1 | India | 0 | 2,023 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 99.2 | 1 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
19 | regional_lab | QCL_0019 | upper_middle_income | urban | 1 | 0 | 0 | 0 | 3 | nevirapine_suspension | ARV | liquid | ambient | 0.08 | border_crossing_point | 0 | India | 0 | 2,024 | 3 | thin_layer_chromatography | fail | substandard | excess_API | 122.1 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 11 | 0 |
20 | regional_lab | QCL_0014 | upper_middle_income | rural | 1 | 0 | 0 | 0 | 8 | diethylcarbamazine_50mg | anthelmintic | tablet | ambient | 0.02 | informal_market | 0 | India | 0 | 2,023 | 3 | thin_layer_chromatography | fail | substandard | dissolution_failure | 95.5 | 0 | 6 | 0 | 1 | 0 | 0 | 0 | 8 | 0 |
21 | regional_lab | QCL_0004 | upper_middle_income | rural | 1 | 0 | 0 | 0 | 3 | amoxicillin_500mg | antibiotic | capsule | ambient | 0.02 | public_health_centre | 1 | Europe | 1 | 2,024 | 1 | thin_layer_chromatography | fail | falsified | no_API_detected | 0 | 0 | 17 | 0 | 1 | 0 | 1 | 0 | 39 | 0 |
22 | regional_lab | QCL_0067 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 4 | ciprofloxacin_500mg | antibiotic | tablet | ambient | 0.04 | wholesale_distributor | 1 | local_SSA | 0 | 2,021 | 3 | HPLC | pass | compliant | not_applicable | 104.2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
23 | regional_lab | QCL_0006 | low_income | rural | 1 | 0 | 0 | 0 | 3 | cotrimoxazole_480mg | antibiotic | tablet | ambient | 0.01 | central_medical_store | 1 | Europe | 0 | 2,023 | 3 | HPLC | pass | compliant | not_applicable | 98 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
24 | regional_lab | QCL_0021 | upper_middle_income | urban | 1 | 0 | 0 | 0 | 4 | doxycycline_100mg | antibiotic | capsule | ambient | 0.03 | public_health_centre | 0 | China | 0 | 2,023 | 3 | UV_spectrophotometry | fail | substandard | insufficient_API | 58.2 | 0 | 14 | 1 | 0 | 0 | 0 | 0 | 5 | 0 |
25 | regional_lab | QCL_0008 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 7 | metronidazole_400mg | antibiotic | tablet | ambient | 0.02 | private_clinic | 0 | unknown | 0 | 2,024 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 96.7 | 1 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
26 | regional_lab | QCL_0031 | low_income | urban | 1 | 0 | 0 | 0 | 3 | artemether_lumefantrine | antimalarial | tablet | ambient | 0.04 | public_hospital_pharmacy | 1 | local_SSA | 0 | 2,020 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 103.1 | 1 | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
27 | regional_lab | QCL_0053 | low_income | rural | 1 | 0 | 0 | 0 | 7 | artesunate_injection | antimalarial | injection | ambient | 0.8 | public_health_centre | 0 | India | 0 | 2,021 | 1 | thin_layer_chromatography | pass | compliant | not_applicable | 96.1 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
28 | regional_lab | QCL_0040 | low_income | urban | 1 | 0 | 0 | 0 | 4 | SP_sulfadoxine_pyrimethamine | antimalarial | tablet | ambient | 0.03 | central_medical_store | 1 | India | 0 | 2,023 | 2 | UV_spectrophotometry | pass | compliant | not_applicable | 96.6 | 1 | 60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
29 | regional_lab | QCL_0068 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 4 | chloroquine_250mg | antimalarial | tablet | ambient | 0.01 | wholesale_distributor | 1 | Europe | 0 | 2,023 | 3 | GPHF_Minilab | pass | compliant | not_applicable | 95.9 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
30 | regional_lab | QCL_0002 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 3 | paracetamol_500mg | analgesic | tablet | ambient | 0.005 | central_medical_store | 1 | India | 0 | 2,020 | 2 | HPLC | pass | compliant | not_applicable | 99.6 | 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
31 | regional_lab | QCL_0070 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 8 | ibuprofen_400mg | analgesic | tablet | ambient | 0.01 | central_medical_store | 0 | India | 0 | 2,024 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 94 | 1 | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
32 | regional_lab | QCL_0077 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 8 | metformin_500mg | antidiabetic | tablet | ambient | 0.01 | private_pharmacy | 1 | India | 0 | 2,024 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 95.2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
33 | regional_lab | QCL_0009 | upper_middle_income | urban | 1 | 0 | 0 | 0 | 3 | amlodipine_5mg | antihypertensive | tablet | ambient | 0.01 | wholesale_distributor | 0 | India | 0 | 2,024 | 3 | HPLC | pass | compliant | not_applicable | 97.8 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
34 | regional_lab | QCL_0010 | upper_middle_income | urban | 1 | 0 | 0 | 0 | 5 | omeprazole_20mg | GI | capsule | ambient | 0.03 | private_pharmacy | 1 | China | 0 | 2,024 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 99.5 | 1 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
35 | regional_lab | QCL_0028 | low_income | urban | 1 | 0 | 0 | 0 | 1 | ORS_sachet | essential | powder | ambient | 0.05 | private_pharmacy | 0 | India | 0 | 2,022 | 1 | GPHF_Minilab | pass | compliant | not_applicable | 96.3 | 1 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
36 | regional_lab | QCL_0031 | low_income | rural | 1 | 0 | 0 | 0 | 6 | oxytocin_10IU | maternal | injection | cold_chain | 0.15 | public_hospital_pharmacy | 0 | India | 0 | 2,023 | 1 | thin_layer_chromatography | pass | compliant | not_applicable | 101.5 | 1 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
37 | regional_lab | QCL_0054 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 6 | insulin_regular | antidiabetic | injection | cold_chain | 5 | central_medical_store | 1 | India | 1 | 2,020 | 4 | UV_spectrophotometry | pass | compliant | not_applicable | 102.3 | 1 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
38 | regional_lab | QCL_0051 | low_income | rural | 1 | 0 | 0 | 0 | 4 | TLD_dolutegravir | ARV | tablet | ambient | 0.12 | public_hospital_pharmacy | 0 | India | 0 | 2,023 | 2 | UV_spectrophotometry | pass | compliant | not_applicable | 101.1 | 1 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
39 | regional_lab | QCL_0042 | low_income | urban | 1 | 0 | 0 | 0 | 5 | nevirapine_suspension | ARV | liquid | ambient | 0.08 | private_pharmacy | 0 | India | 0 | 2,020 | 2 | HPLC | pass | compliant | not_applicable | 99.5 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
40 | regional_lab | QCL_0013 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 3 | diethylcarbamazine_50mg | anthelmintic | tablet | ambient | 0.02 | wholesale_distributor | 0 | India | 0 | 2,024 | 1 | GPHF_Minilab | fail | substandard | dissolution_failure | 108.4 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 1,241 | 0 |
41 | regional_lab | QCL_0024 | low_income | peri_urban | 1 | 0 | 0 | 0 | 1 | amoxicillin_500mg | antibiotic | capsule | ambient | 0.02 | private_pharmacy | 1 | India | 0 | 2,024 | 1 | thin_layer_chromatography | pass | compliant | not_applicable | 99.8 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
42 | regional_lab | QCL_0062 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 2 | ciprofloxacin_500mg | antibiotic | tablet | ambient | 0.04 | public_hospital_pharmacy | 0 | China | 0 | 2,021 | 1 | GPHF_Minilab | pass | compliant | not_applicable | 98.4 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
43 | regional_lab | QCL_0058 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 3 | cotrimoxazole_480mg | antibiotic | tablet | ambient | 0.01 | public_health_centre | 0 | India | 0 | 2,023 | 1 | UV_spectrophotometry | fail | substandard | uniformity_failure | 100.8 | 1 | 21 | 0 | 0 | 0 | 0 | 0 | 33 | 1 |
44 | regional_lab | QCL_0003 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 4 | doxycycline_100mg | antibiotic | capsule | ambient | 0.03 | central_medical_store | 1 | India | 0 | 2,024 | 4 | HPLC | pass | compliant | not_applicable | 93.4 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
45 | regional_lab | QCL_0033 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 6 | metronidazole_400mg | antibiotic | tablet | ambient | 0.02 | public_health_centre | 0 | India | 0 | 2,024 | 3 | HPLC | pass | compliant | not_applicable | 98.7 | 1 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
46 | regional_lab | QCL_0028 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 6 | artemether_lumefantrine | antimalarial | tablet | ambient | 0.04 | public_hospital_pharmacy | 1 | India | 0 | 2,021 | 3 | HPLC | pass | compliant | not_applicable | 99.3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
47 | regional_lab | QCL_0078 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 2 | artesunate_injection | antimalarial | injection | ambient | 0.8 | central_medical_store | 1 | China | 0 | 2,021 | 1 | HPLC | pass | compliant | not_applicable | 98.7 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
48 | regional_lab | QCL_0009 | upper_middle_income | rural | 1 | 0 | 0 | 0 | 2 | SP_sulfadoxine_pyrimethamine | antimalarial | tablet | ambient | 0.03 | private_clinic | 1 | unknown | 0 | 2,023 | 4 | UV_spectrophotometry | fail | substandard | insufficient_API | 75.4 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 17 | 0 |
49 | regional_lab | QCL_0009 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 4 | chloroquine_250mg | antimalarial | tablet | ambient | 0.01 | wholesale_distributor | 1 | China | 0 | 2,022 | 4 | HPLC | pass | compliant | not_applicable | 102.5 | 1 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
50 | regional_lab | QCL_0043 | low_income | urban | 1 | 0 | 0 | 0 | 8 | paracetamol_500mg | analgesic | tablet | ambient | 0.005 | public_hospital_pharmacy | 1 | unknown | 0 | 2,023 | 3 | GPHF_Minilab | pass | compliant | not_applicable | 100.8 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
51 | regional_lab | QCL_0070 | low_income | rural | 1 | 0 | 0 | 0 | 5 | ibuprofen_400mg | analgesic | tablet | ambient | 0.01 | central_medical_store | 1 | local_SSA | 0 | 2,023 | 1 | HPLC | pass | compliant | not_applicable | 95.5 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
52 | regional_lab | QCL_0005 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 5 | metformin_500mg | antidiabetic | tablet | ambient | 0.01 | central_medical_store | 1 | India | 0 | 2,021 | 4 | HPLC | pass | compliant | not_applicable | 99.7 | 1 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
53 | regional_lab | QCL_0033 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 7 | amlodipine_5mg | antihypertensive | tablet | ambient | 0.01 | private_pharmacy | 0 | local_SSA | 0 | 2,024 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 101.6 | 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
54 | regional_lab | QCL_0059 | low_income | peri_urban | 1 | 0 | 0 | 0 | 7 | omeprazole_20mg | GI | capsule | ambient | 0.03 | public_hospital_pharmacy | 1 | local_SSA | 0 | 2,023 | 3 | thin_layer_chromatography | fail | substandard | insufficient_API | 70.6 | 0 | 38 | 1 | 0 | 0 | 0 | 0 | 4 | 0 |
55 | regional_lab | QCL_0061 | low_income | rural | 1 | 0 | 0 | 0 | 7 | ORS_sachet | essential | powder | ambient | 0.05 | private_pharmacy | 0 | India | 0 | 2,023 | 1 | HPLC | pass | compliant | not_applicable | 99 | 1 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
56 | regional_lab | QCL_0014 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 10 | oxytocin_10IU | maternal | injection | cold_chain | 0.15 | border_crossing_point | 0 | China | 0 | 2,021 | 4 | UV_spectrophotometry | fail | substandard | disintegration_failure | 90.8 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 16 | 1 |
57 | regional_lab | QCL_0004 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 3 | insulin_regular | antidiabetic | injection | cold_chain | 5 | central_medical_store | 1 | India | 0 | 2,023 | 2 | GPHF_Minilab | pass | compliant | not_applicable | 99.7 | 1 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
58 | regional_lab | QCL_0020 | upper_middle_income | rural | 1 | 0 | 0 | 0 | 4 | TLD_dolutegravir | ARV | tablet | ambient | 0.12 | private_clinic | 0 | local_SSA | 0 | 2,024 | 2 | GPHF_Minilab | pass | compliant | not_applicable | 103.7 | 1 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
59 | regional_lab | QCL_0026 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 5 | nevirapine_suspension | ARV | liquid | ambient | 0.08 | private_pharmacy | 1 | local_SSA | 0 | 2,024 | 2 | UV_spectrophotometry | pass | compliant | not_applicable | 99.3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
60 | regional_lab | QCL_0026 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 1 | diethylcarbamazine_50mg | anthelmintic | tablet | ambient | 0.02 | private_pharmacy | 0 | India | 0 | 2,023 | 1 | thin_layer_chromatography | fail | falsified | expired_repackaged | 84.8 | 1 | 13 | 0 | 1 | 1 | 0 | 0 | 36 | 0 |
61 | regional_lab | QCL_0043 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 3 | amoxicillin_500mg | antibiotic | capsule | ambient | 0.02 | public_hospital_pharmacy | 1 | India | 0 | 2,022 | 4 | GPHF_Minilab | fail | substandard | dissolution_failure | 92.9 | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 31 | 0 |
62 | regional_lab | QCL_0038 | low_income | rural | 1 | 0 | 0 | 0 | 4 | ciprofloxacin_500mg | antibiotic | tablet | ambient | 0.04 | public_hospital_pharmacy | 1 | China | 0 | 2,022 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 94.2 | 1 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
63 | regional_lab | QCL_0060 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 3 | cotrimoxazole_480mg | antibiotic | tablet | ambient | 0.01 | public_health_centre | 0 | local_SSA | 0 | 2,021 | 2 | GPHF_Minilab | pass | compliant | not_applicable | 102 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
64 | regional_lab | QCL_0027 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 3 | doxycycline_100mg | antibiotic | capsule | ambient | 0.03 | private_pharmacy | 1 | India | 0 | 2,022 | 1 | HPLC | fail | substandard | insufficient_API | 59.7 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 9 | 0 |
65 | regional_lab | QCL_0005 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 6 | metronidazole_400mg | antibiotic | tablet | ambient | 0.02 | private_pharmacy | 0 | China | 0 | 2,024 | 1 | HPLC | pass | compliant | not_applicable | 95.4 | 1 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
66 | regional_lab | QCL_0076 | low_income | peri_urban | 1 | 0 | 0 | 0 | 3 | artemether_lumefantrine | antimalarial | tablet | ambient | 0.04 | wholesale_distributor | 1 | India | 0 | 2,022 | 2 | UV_spectrophotometry | pass | compliant | not_applicable | 93.6 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
67 | regional_lab | QCL_0022 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 5 | artesunate_injection | antimalarial | injection | ambient | 0.8 | public_hospital_pharmacy | 1 | India | 1 | 2,023 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 96.5 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
68 | regional_lab | QCL_0009 | low_income | rural | 1 | 0 | 0 | 0 | 3 | SP_sulfadoxine_pyrimethamine | antimalarial | tablet | ambient | 0.03 | public_hospital_pharmacy | 1 | China | 0 | 2,020 | 3 | thin_layer_chromatography | pass | compliant | not_applicable | 93 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
69 | regional_lab | QCL_0045 | low_income | rural | 1 | 0 | 0 | 0 | 5 | chloroquine_250mg | antimalarial | tablet | ambient | 0.01 | private_clinic | 0 | unknown | 0 | 2,024 | 4 | HPLC | pass | compliant | not_applicable | 99.2 | 1 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
70 | regional_lab | QCL_0031 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 5 | paracetamol_500mg | analgesic | tablet | ambient | 0.005 | border_crossing_point | 0 | India | 0 | 2,022 | 4 | GPHF_Minilab | fail | substandard | dissolution_failure | 101.5 | 0 | 4 | 1 | 0 | 0 | 0 | 0 | 18 | 1 |
71 | regional_lab | QCL_0046 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 3 | ibuprofen_400mg | analgesic | tablet | ambient | 0.01 | central_medical_store | 1 | USA | 0 | 2,020 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 98.4 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
72 | regional_lab | QCL_0029 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 5 | metformin_500mg | antidiabetic | tablet | ambient | 0.01 | central_medical_store | 1 | India | 1 | 2,024 | 1 | HPLC | pass | compliant | not_applicable | 97.5 | 1 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
73 | regional_lab | QCL_0063 | low_income | rural | 1 | 0 | 0 | 0 | 4 | amlodipine_5mg | antihypertensive | tablet | ambient | 0.01 | wholesale_distributor | 0 | unknown | 0 | 2,024 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 98.9 | 1 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
74 | regional_lab | QCL_0031 | upper_middle_income | rural | 1 | 0 | 0 | 0 | 6 | omeprazole_20mg | GI | capsule | ambient | 0.03 | public_hospital_pharmacy | 1 | China | 0 | 2,024 | 3 | UV_spectrophotometry | fail | falsified | no_API_detected | 0 | 0 | 60 | 1 | 0 | 0 | 0 | 0 | 79 | 0 |
75 | regional_lab | QCL_0045 | low_income | urban | 1 | 0 | 0 | 0 | 6 | ORS_sachet | essential | powder | ambient | 0.05 | informal_market | 0 | unknown | 0 | 2,022 | 1 | HPLC | fail | substandard | moisture_content | 92.2 | 1 | 57 | 1 | 1 | 1 | 0 | 0 | 79 | 0 |
76 | regional_lab | QCL_0064 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 4 | oxytocin_10IU | maternal | injection | cold_chain | 0.15 | private_clinic | 0 | unknown | 0 | 2,023 | 1 | UV_spectrophotometry | pass | compliant | not_applicable | 100.1 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
77 | regional_lab | QCL_0057 | low_income | rural | 1 | 0 | 0 | 0 | 5 | insulin_regular | antidiabetic | injection | cold_chain | 5 | border_crossing_point | 0 | local_SSA | 0 | 2,024 | 3 | UV_spectrophotometry | fail | substandard | disintegration_failure | 86.2 | 1 | 8 | 1 | 0 | 0 | 0 | 0 | 10 | 0 |
78 | regional_lab | QCL_0039 | low_income | rural | 1 | 0 | 0 | 0 | 5 | TLD_dolutegravir | ARV | tablet | ambient | 0.12 | public_hospital_pharmacy | 0 | India | 0 | 2,021 | 2 | HPLC | pass | compliant | not_applicable | 99.3 | 1 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
79 | regional_lab | QCL_0067 | low_income | peri_urban | 1 | 0 | 0 | 0 | 3 | nevirapine_suspension | ARV | liquid | ambient | 0.08 | private_clinic | 0 | India | 0 | 2,023 | 1 | thin_layer_chromatography | pass | compliant | not_applicable | 101.1 | 1 | 57 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
80 | regional_lab | QCL_0022 | low_income | urban | 1 | 0 | 0 | 0 | 5 | diethylcarbamazine_50mg | anthelmintic | tablet | ambient | 0.02 | public_hospital_pharmacy | 1 | India | 0 | 2,021 | 1 | thin_layer_chromatography | pass | compliant | not_applicable | 102.9 | 1 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
81 | regional_lab | QCL_0050 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 4 | amoxicillin_500mg | antibiotic | capsule | ambient | 0.02 | private_pharmacy | 1 | China | 0 | 2,023 | 4 | UV_spectrophotometry | pass | compliant | not_applicable | 105 | 1 | 28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
82 | regional_lab | QCL_0006 | upper_middle_income | rural | 1 | 0 | 0 | 0 | 6 | ciprofloxacin_500mg | antibiotic | tablet | ambient | 0.04 | private_clinic | 0 | India | 0 | 2,021 | 4 | HPLC | pass | compliant | not_applicable | 97.9 | 1 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
83 | regional_lab | QCL_0054 | low_income | rural | 1 | 0 | 0 | 0 | 5 | cotrimoxazole_480mg | antibiotic | tablet | ambient | 0.01 | public_health_centre | 0 | India | 0 | 2,022 | 1 | UV_spectrophotometry | fail | substandard | impurity_above_limit | 91.9 | 1 | 23 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
84 | regional_lab | QCL_0071 | lower_middle_income | urban | 1 | 0 | 0 | 0 | 4 | doxycycline_100mg | antibiotic | capsule | ambient | 0.03 | private_pharmacy | 1 | unknown | 0 | 2,023 | 3 | thin_layer_chromatography | pass | compliant | not_applicable | 100.4 | 1 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
85 | regional_lab | QCL_0007 | low_income | peri_urban | 1 | 0 | 0 | 0 | 3 | metronidazole_400mg | antibiotic | tablet | ambient | 0.02 | border_crossing_point | 0 | USA | 0 | 2,022 | 4 | HPLC | fail | falsified | wrong_labelling | 96.3 | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
86 | regional_lab | QCL_0035 | low_income | rural | 1 | 0 | 0 | 0 | 5 | artemether_lumefantrine | antimalarial | tablet | ambient | 0.04 | informal_market | 0 | India | 0 | 2,024 | 4 | GPHF_Minilab | fail | substandard | microbial_contamination | 90.4 | 1 | 19 | 0 | 0 | 0 | 0 | 0 | 13 | 0 |
87 | regional_lab | QCL_0078 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 8 | artesunate_injection | antimalarial | injection | ambient | 0.8 | border_crossing_point | 0 | local_SSA | 0 | 2,024 | 1 | GPHF_Minilab | fail | substandard | dissolution_failure | 101.5 | 0 | 6 | 1 | 0 | 0 | 0 | 0 | 9 | 0 |
88 | regional_lab | QCL_0048 | upper_middle_income | rural | 1 | 0 | 0 | 0 | 6 | SP_sulfadoxine_pyrimethamine | antimalarial | tablet | ambient | 0.03 | public_health_centre | 0 | China | 0 | 2,023 | 2 | HPLC | fail | substandard | insufficient_API | 45.8 | 0 | 52 | 1 | 0 | 0 | 0 | 0 | 4 | 0 |
89 | regional_lab | QCL_0018 | upper_middle_income | urban | 1 | 0 | 0 | 0 | 4 | chloroquine_250mg | antimalarial | tablet | ambient | 0.01 | central_medical_store | 1 | local_SSA | 0 | 2,024 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 97.6 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
90 | regional_lab | QCL_0002 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 6 | paracetamol_500mg | analgesic | tablet | ambient | 0.005 | public_health_centre | 1 | India | 1 | 2,024 | 4 | HPLC | pass | compliant | not_applicable | 96.2 | 1 | 23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
91 | regional_lab | QCL_0003 | upper_middle_income | peri_urban | 1 | 0 | 0 | 0 | 5 | ibuprofen_400mg | analgesic | tablet | ambient | 0.01 | border_crossing_point | 0 | India | 0 | 2,021 | 3 | thin_layer_chromatography | fail | substandard | impurity_above_limit | 87.4 | 1 | 7 | 1 | 1 | 0 | 0 | 0 | 29 | 0 |
92 | regional_lab | QCL_0020 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 6 | metformin_500mg | antidiabetic | tablet | ambient | 0.01 | private_pharmacy | 1 | India | 1 | 2,022 | 2 | thin_layer_chromatography | pass | compliant | not_applicable | 98.1 | 1 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
93 | regional_lab | QCL_0076 | lower_middle_income | peri_urban | 1 | 0 | 0 | 0 | 6 | amlodipine_5mg | antihypertensive | tablet | ambient | 0.01 | private_pharmacy | 0 | China | 0 | 2,023 | 2 | GPHF_Minilab | pass | compliant | not_applicable | 99.9 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
94 | regional_lab | QCL_0047 | low_income | rural | 1 | 0 | 0 | 0 | 3 | omeprazole_20mg | GI | capsule | ambient | 0.03 | central_medical_store | 1 | local_SSA | 0 | 2,022 | 1 | UV_spectrophotometry | pass | compliant | not_applicable | 99.3 | 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
95 | regional_lab | QCL_0075 | lower_middle_income | rural | 1 | 0 | 0 | 0 | 4 | ORS_sachet | essential | powder | ambient | 0.05 | informal_market | 0 | unknown | 0 | 2,023 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 101.3 | 1 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
96 | regional_lab | QCL_0053 | low_income | peri_urban | 1 | 0 | 0 | 0 | 9 | oxytocin_10IU | maternal | injection | cold_chain | 0.15 | private_pharmacy | 0 | India | 0 | 2,022 | 4 | HPLC | fail | substandard | dissolution_failure | 75.7 | 0 | 118 | 1 | 1 | 1 | 1 | 0 | 65 | 0 |
97 | regional_lab | QCL_0055 | low_income | peri_urban | 1 | 0 | 0 | 0 | 2 | insulin_regular | antidiabetic | injection | cold_chain | 5 | informal_market | 0 | China | 0 | 2,020 | 1 | thin_layer_chromatography | pass | compliant | not_applicable | 99.5 | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
98 | regional_lab | QCL_0027 | low_income | urban | 1 | 0 | 0 | 0 | 8 | TLD_dolutegravir | ARV | tablet | ambient | 0.12 | public_hospital_pharmacy | 1 | local_SSA | 0 | 2,020 | 3 | UV_spectrophotometry | pass | compliant | not_applicable | 95.8 | 1 | 112 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
99 | regional_lab | QCL_0018 | low_income | peri_urban | 1 | 0 | 0 | 0 | 2 | nevirapine_suspension | ARV | liquid | ambient | 0.08 | public_health_centre | 0 | China | 0 | 2,021 | 3 | thin_layer_chromatography | pass | compliant | not_applicable | 102.2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
100 | regional_lab | QCL_0024 | upper_middle_income | urban | 1 | 0 | 0 | 0 | 9 | diethylcarbamazine_50mg | anthelmintic | tablet | ambient | 0.02 | private_clinic | 1 | local_SSA | 0 | 2,020 | 4 | thin_layer_chromatography | pass | compliant | not_applicable | 102.4 | 1 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.